Cure Parkinson’s launches £2m funding call for research into combination therapies – deadline 24th November

Applications are open for preclinical and clinical projects to develop combination therapies for disease modification in Parkinson’s.

Preclinical applications can request up to £300,000 for 1-3 year projects. In keeping with Cure Parkinson’s funding remit, preclinical projects should be within five years of translation to clinical testing in people with Parkinson’s. Clinical applications can request in the region of £1 million over 2-4 years, to fund clinical trials or sub-studies of trials involving people with Parkinson’s.

To be considered for funding, please complete the expression of interest form, drug CV (one for each agent) and commercial entity form (if applicable) and email to research@cureparkinsons.org.uk by 11.59pm (GMT) Monday 24 November 2025.

For more information about this funding call, and how to apply, please refer to the applicant guidance on this website or contact the Cure Parkinson’s research team at research@cureparkinsons.org.uk.

Further Information

---

Cure Parkinson’s is looking for new members of its Research Committee, which makes funding recommendations and helps deliver their Research Strategy. Applications are invited from academics, clinicians, regulatory experts and people with Parkinson’s who have expertise in medical research and the grant review process. For details on the specific roles and how to apply, please visit this website.

Posted on 22/10/2025